Jen JenYehMD

Endocrine, Melanoma, Pancreas, Surgical Oncology (Other than Breast)

Professor, Departments of Surgery and Pharmacology, University of North Carolina-Chapel Hill School of Medicine; Vice Chair for Research, Department of Surgery

Join to view full profile

Dr. Yeh is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Yeh's full profile

Already have an account?

Office
101 Manning Dr
Chapel Hill, NC 27599
Phone+1 919-966-8596

Fax+1 919-843-5515

Education & Training

Memorial Sloan Kettering Cancer CenterFellowship, Complex General Surgical Oncology, 2003 - 2005
Boston University Medical CenterResidency, Surgery, 1996 - 2003
Johns Hopkins University School of MedicineClass of 1996

Awards, Honors, & Recognition

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Fellow (FACS) American College of Surgeons

Publications & Presentations

PubMed

New Onset Diabetes in Pancreatic Adenocarcinoma Does Not Correlate With Molecular Subtype.
Hannah E Trembath, Michelle E LaBella, Joseph F Kearney, Arthi Hariharan, Sandra Zarmer
Journal of Surgical Oncology. 2024-12-22
CAFomics: convergence to translation for precision stroma approaches.
Ian C McCabe, Xianlu L Peng, Joseph F Kearney, Jen Jen Yeh
Carcinogenesis. 2024-11-22
Purity Independent Subtyping of Tumors (PurIST) Pancreatic Cancer Classifier: Analytic Validation of a 16-RNA Expression Signature Distinguishing Basal and Classical S...
Yan Li, Jason D Merker, Rachana Kshatriya, Dimitri G Trembath, Ashley B Morrison
The Journal of Molecular Diagnostics. 2024-11-01

Press Mentions

Rashid Awarded Grant to Develop AI Tool That Recommends Optimal Clinical Trials to Pancreatic Cancer PatientsSeptember 24th, 2024
Device Targets Hard-to-Treat Pancreatic CancerFebruary 24th, 2016
Device Hits Pancreatic Tumors Hard with Toxic Four-Drug Cocktail, Sparing the BodyFebruary 8th, 2016
Join now to see all

Grant Support

Targeting Ras-Ral Gef-Ral Effector Signaling For Pancreatic Cancer TreatmentNational Cancer Institute2010–2012
Nanoscale Metal-Organic Frameworks For Imaging And Therapy Of Pancreatic CancerNational Cancer Institute2010–2011